Cintia Folgueira
Overview
Explore the profile of Cintia Folgueira including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
544
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cicuendez B, Mora A, Lopez J, Curtabbi A, Perez-Garcia J, Porteiro B, et al.
Nat Commun
. 2025 Jan;
16(1):229.
PMID: 39805849
Obesity poses a global health challenge, demanding a deeper understanding of adipose tissue (AT) and its mitochondria. This study describes the role of the mitochondrial protein Methylation-controlled J protein (MCJ/DnaJC15)...
2.
Aboy-Pardal M, Guadamillas M, Guerrero C, Catala-Montoro M, Toledano-Donado M, Terres-Dominguez S, et al.
Nat Commun
. 2024 Nov;
15(1):10102.
PMID: 39609408
Adipocytes expand massively to accommodate excess energy stores and protect the organism from lipotoxicity. Adipose tissue expandability is at the center of disorders such as obesity and lipodystrophy; however, little...
3.
Valdecantos M, Ruiz L, Folgueira C, Rada P, Gomez-Santos B, Solas M, et al.
Nat Commun
. 2024 Nov;
15(1):10342.
PMID: 39609390
Bariatric surgery is effective for the treatment and remission of obesity and type 2 diabetes, but pharmacological approaches which exert similar metabolic adaptations are needed to avoid post-surgical complications. Here...
4.
Herrera-Melle L, Cicuendez B, Lopez J, Dumesic P, Wilensky S, Rodriguez E, et al.
Acta Physiol (Oxf)
. 2024 Oct;
240(11):e14234.
PMID: 39361268
Aims: Skeletal muscle, with its remarkable plasticity and dynamic adaptation, serves as a cornerstone of locomotion and metabolic homeostasis in the human body. Muscle tissue, with its extraordinary capacity for...
5.
Folgueira C, Herrera-Melle L, Lopez J, Galvan-Alvarez V, Martin-Rincon M, Cuartero M, et al.
Sci Adv
. 2024 Aug;
10(33):eadn5993.
PMID: 39141732
Skeletal muscle has gained recognition as an endocrine organ releasing myokines upon contraction during physical exercise. These myokines exert both local and pleiotropic health benefits, underscoring the crucial role of...
6.
Duquenne M, Deligia E, Folgueira C, Bourouh C, Caron E, Pfrieger F, et al.
Mol Metab
. 2024 Jul;
87:101996.
PMID: 39047908
Objectives: In Western society, high-caloric diets rich in fats and sugars have fueled the obesity epidemic and its related disorders. Disruption of the body-brain communication, crucial for maintaining glucose and...
7.
Ferreira V, Folgueira C, Lorenzo A, Rodriguez-Lopez A, Gonzalez-Iglesias E, Zubiaur P, et al.
Biochim Biophys Acta Mol Basis Dis
. 2024 May;
1870(5):167227.
PMID: 38733774
Olanzapine (OLA) is a highly obesogenic second-generation antipsychotic (SGA). Recently we demonstrated that, contrarily to OLA oral treatment, intraperitoneal (i.p.) administration resulted in weight loss and absence of hepatic steatosis...
8.
Cicuendez B, Perez-Garcia J, Folgueira C
Nutrients
. 2024 Feb;
16(3).
PMID: 38337707
As the global obesity rate increases, so does the urgency to find effective anti-obesity drugs. In the search for therapeutic targets, central nervous system (CNS) mechanisms engaged in the regulation...
9.
Ferreira V, Folgueira C, Garcia-Altares M, Guillen M, Ruiz-Rosario M, DiNunzio G, et al.
Redox Biol
. 2023 May;
63:102741.
PMID: 37230004
Olanzapine (OLA), a widely used second-generation antipsychotic (SGA), causes weight gain and metabolic alterations when administered orally to patients. Recently, we demonstrated that, contrarily to the oral treatment which induces...
10.
Ferreira V, Folgueira C, Guillen M, Zubiaur P, Navares M, Sarsenbayeva A, et al.
Metabolism
. 2022 Oct;
137:155335.
PMID: 36272468
Background: Second-generation antipsychotics (SGAs) are a mainstay therapy for schizophrenia. SGA-treated patients present higher risk for weight gain, dyslipidemia and hyperglycemia. Herein, we evaluated the effects of olanzapine (OLA), widely...